![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 47.00 | 45.60 | 47.50 | - | 2,010 | 08:41:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 11.58M | -28.29M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/2/2020 07:56 | What one has to be aware is that even without any news, the share price will be sensitive to loads of cash released from oilers, miners, airlines and many sectors hit by the virus, coming to pharmas and gold. - - - | ![]() fuji99 | |
25/2/2020 07:55 | MMS will manipulate it first thing ! | dropperking | |
25/2/2020 07:53 | Does not need FDA approval for sales to ASia and Europe. Gearing up for big jump in share price as orders will now roll in | ![]() inv | |
25/2/2020 07:52 | Traders profit take first 10 mins maybe | dropperking | |
25/2/2020 07:52 | Someone short munchkin ;-) | ![]() jayrh | |
25/2/2020 07:47 | Classic p&d basedOn fearmongering byShady characters | ![]() andymunchkin | |
25/2/2020 07:43 | The other single piece of news could be a takeover bid ? Who knows ? ... | ![]() fuji99 | |
25/2/2020 07:42 | Health minister on TV, getting test kits ready for home testing, | still waiting | |
25/2/2020 07:41 | It's only been what 2 weeks since application, patience required, you won't get an update other than it's approved or not, since it's already acquired the CE mark, and its a test not a medicine I expect a result within the next two weeks IMO | jasonblue66 | |
25/2/2020 07:39 | Some poor souls will not only be hit by the FDA this week, but by China and large orders from Europe (France, UK etc.). A week has 5 working days and the US start work at 14.00 pm GMT everyday... | ![]() fuji99 | |
25/2/2020 07:35 | FDA fast asleep at this time of day I'd imagine | ![]() martin3042 | |
25/2/2020 07:33 | He has a good point after all the blatant ramping by various shady characters. The question still remains, where is FDA?. | ![]() thehitman1 | |
25/2/2020 07:28 | Ammu12 your comments move me to tears of laughter though. | ![]() tracy_moore | |
25/2/2020 07:28 | See what happens on open , if a feel good price on the rise then the rerate drop ! Back in the driving seat . GLA | dropperking | |
25/2/2020 07:17 | Nah not invested just trading this.Relax white, my comments don't move the share price | ![]() ammu12 | |
25/2/2020 07:12 | Moderna (NASDAQ:MRNA) +15.1% after-hours on news it shipped the first batch of its mRNA-1273 vaccine against the novel coronavirus to U.S. government researchers to be used in a planned phase 1 study in the U.S. | ![]() losses | |
25/2/2020 07:04 | So where is the fda approval ? | ![]() ammu12 | |
25/2/2020 06:39 | News is imminent. Would not want to be out of these right now. Hope Dave4545 is holding? Wouldn’t like to see him miss out! 😆 | ![]() intheknow69 | |
25/2/2020 01:28 | We’re all doomed but I’m enjoying the winter heat and sunshine in SE Asia, hope it’s not too cold 🥶 in Blighty | ![]() ny boy | |
25/2/2020 00:11 | Long_and_Short24 Feb '20 - 23:13 - 121 of 124 0 1 1 Classic P&D share. Anyone have put some efforts that would happen if this company failed to put the product which will not be effective or simply say if FDA reject it. Anyone thought what would the share price then ? 20p ? Why to take a 80% drop chance ? It’s not even a binary shot. ——— 10p | ![]() andymunchkin | |
25/2/2020 00:01 | hxtps://www.thisismo | ![]() hope67 | |
24/2/2020 23:46 | And friends that live there. | ![]() tez123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions